Komanasin N, Catto A J, Futers T S, van Hylckama Vlieg A, Rosendaal F R, Ariëns R A S
Academic Unit of Molecular Vascular Medicine, Leeds Institute for Genetics, Health and Therapeutics, University of Leeds, UK.
J Thromb Haemost. 2005 Nov;3(11):2487-96. doi: 10.1111/j.1538-7836.2005.01624.x.
Factor (F)XIII B-subunit, which plays a carrier role for zymogen FXIIIA, is highly polymorphic, but the molecular basis for these polymorphisms and their relationship to disease remains unknown.
To screen the FXIIIB gene coding region for common variation and analyze possible functional effects.
We examined the FXIIIB gene by PCR-SSCP and identified three common single nucleotide polymorphisms: A8259G, C29470T and A30899G. A8259G results in substitution of His95Arg in the second Sushi domain. An FXIII tetramer ELISA was developed to analyze B-subunit dissociation from A-subunit (leading to access to the catalytic site of FXIII). Increased subunit dissociation, 0.51 vs. 0.45 (fraction of total tetramer), was found in plasma from subjects possessing the Arg-allele. However, when the variants were purified to homogeneity and binding was analyzed by steady-state kinetics, no difference was observed. The relationship between His95Arg and venous thrombosis was investigated in 214 patients and 291 controls from Leeds. His/Arg + Arg/Arg genotypes were more frequent in patients than controls (22.4% vs. 15.1%). His95Arg was also investigated in the Leiden Thrombophilia Study, in which a similar difference was observed for 471 patients vs. 472 controls (18.5% vs. 14.0%), for a pooled odds ratio (OR) of 1.5 (CI95 1.1-2.0).
We have identified three FXIIIB polymorphisms, one of which codes for substitution of His95Arg. The Arg95 variant associates with a moderately increased risk for venous thrombosis, and with increased dissociation of the FXIII subunits in plasma, although in vitro steady-state binding between purified subunits was not affected.
因子(F)XIII B亚基作为酶原FXIIIA的载体,具有高度多态性,但其多态性的分子基础及其与疾病的关系尚不清楚。
筛查FXIIIB基因编码区的常见变异并分析可能的功能影响。
我们通过PCR-SSCP检测FXIIIB基因,鉴定出三个常见的单核苷酸多态性:A8259G、C29470T和A30899G。A8259G导致第二个寿司结构域中的His95被Arg取代。开发了一种FXIII四聚体ELISA来分析B亚基与A亚基的解离(从而暴露FXIII的催化位点)。在携带Arg等位基因的受试者血浆中发现亚基解离增加,分别为0.51和0.45(占总四聚体的比例)。然而,当将变体纯化至同质并通过稳态动力学分析结合情况时,未观察到差异。在来自利兹的214例患者和291例对照中研究了His95Arg与静脉血栓形成的关系。患者中His/Arg + Arg/Arg基因型比对照更常见(22.4%对15.1%)。在莱顿血栓形成倾向研究中也对His95Arg进行了研究,在471例患者与472例对照中观察到类似差异(18.5%对14.0%),合并优势比(OR)为1.5(95%CI 1.1-2.0)。
我们鉴定出三个FXIIIB多态性,其中一个编码His95被Arg取代。Arg95变体与静脉血栓形成风险适度增加相关,且与血浆中FXIII亚基解离增加相关,尽管纯化亚基之间的体外稳态结合未受影响。